V001-2257 Screening compound: N-[(furan-2-yl)methyl]-N-{[1-(2-methoxyethyl)-2-[(3-methoxyphenyl)methanesulfonyl]-1H-imidazol-5-yl]methyl}-2-phenylacetamide

V001-2257 Screening compound: N-[(furan-2-yl)methyl]-N-{[1-(2-methoxyethyl)-2-[(3-methoxyphenyl)methanesulfonyl]-1H-imidazol-5-yl]methyl}-2-phenylacetamide
V001-2257 Screening compound: N-[(furan-2-yl)methyl]-N-{[1-(2-methoxyethyl)-2-[(3-methoxyphenyl)methanesulfonyl]-1H-imidazol-5-yl]methyl}-2-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V001-2257
N-[(furan-2-yl)methyl]-N-{[1-(2-methoxyethyl)-2-[(3-methoxyphenyl)methanesulfonyl]-1H-imidazol-5-yl]methyl}-2-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V001-2257

Molecular Formula

C28H31N3O6S (C28 H31 N3 O6 S)

Compound Name

N-[(furan-2-yl)methyl]-N-{[1-(2-methoxyethyl)-2-[(3-methoxyphenyl)methanesulfonyl]-1H-imidazol-5-yl]methyl}-2-phenylacetamide

IUPAC name

N-[(furan-2-yl)methyl]-N-{[1-(2-methoxyethyl)-2-[(3-methoxyphenyl)methanesulfonyl]-1H-imidazol-5-yl]methyl}-2-phenylacetamide

SMILES

COCCn1c(S(Cc2cc(OC)ccc2)(=O)=O)ncc1CN(Cc1ccco1)C(Cc1ccccc1)=O

InChI

InChI=1S/C28H31N3O6S/c1-35-15-13-31-24(18-29-28(31)38(33,34)21-23-10-6-11-25(16-23)36-2)19-30(20-26-12-7-14-37-26)27(32)17-22-8-4-3-5-9-22/h3-12,14,16,18H,13,15,17,19-21H2,1-2H3

InChI Key

RAJJCSSEOINZKM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19824224

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

537.64

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

14.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.673

Distribution Coefficient, logD

3.673

Water Solubility, LogSw

-3.83

Polar Surface Area

79.949

Acid Dissociation Constant (pKa)

17.05

Base Dissociation Constant (pKb)

-1.65

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

V001-2257 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V001-2257 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V001-2257?
Check Price and Availability of V001-2257, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V001-2257 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V001-2257
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V001-2257
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V001-2257 available by request